A study has shown a positive result regarding the testing of the newly developed cancer vaccine to remove cancer cells in a breast cancer patient at Mayo Clinic. Lee Mercker is a first patient from Florida who has participated in a clinical trial for a new vaccine for cancer cells. Lee Mercker was diagnosed with the early stage of breast cancer in March of this year. She reported that she had breast cancer with the “DCIS Stage Zero” and the cancer cells were not spread throughout the body. After diagnosed with the early stage of cancer, she chose an option to join a clinical trial study, which is conducted for potentially life-saving vaccines. This vaccine is developed to kill the cancer cells and prevent them from reoccurrence.
Along with clinical trials, she had two more options, such as undergoing a procedure of mastectomy in which breasts are removed and having a lumpectomy in which cancer cells are removed. The Clinical trial program was conducted at the campus of Jacksonville clinics for 12 weeks. This program was entailed with a series of vaccine shots and ongoing tests. According to an oncologist, Dr. Saranya Chumsri from the world-renowned medical center Mayo Clinic, the vaccine is about to stimulate a patient’s own immune response so that immune cells such as t-cells will attack the cancer cells.
Lee Mercker was still required to go through the procedure of mastectomy, a process of surgical removal of one or both breasts, partially or completely. Lee Mercker’s breast tissues are available for the other scientists and researchers to access how the vaccine works. This treatment and clinical trial are also conducted on another patient and he also has shown a positive result for the vaccine. Dr. Saranya Chumsri stated that the clinical trial study is also conducting on other cancer patients who are suffering from various stages of cancer.